Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 12/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | KDM1A | O60341 | 5/20 | 0.41 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18059592 | 1.00 | MAOA (0.49) | MAOAKCNH2KDM1AKDM1BMAOB | |
| SCHEMBL2509465 | 0.94 | MAOA (0.50) | MAOAKCNH2KDM1AKDM1BMAOB | |
| SCHEMBL18059602 | 0.94 | MAOA (0.50) | MAOAKCNH2KDM1AKDM1BMAOB | |
| SCHEMBL18059590 | 0.90 | MAOA (0.53) | MAOAKCNH2MAOB | |
| SCHEMBL18059589 | 0.90 | MAOA (0.53) | MAOAKCNH2MAOB | |
| SCHEMBL2478684 | 0.88 | MAOA (0.49) | MAOAKCNH2MAOB | |
| SCHEMBL18059595 | 0.85 | MAOA (0.56) | MAOAKCNH2MAOB | |
| SCHEMBL2483451 | 0.85 | MAOA (0.56) | MAOAKCNH2MAOB | |
| SCHEMBL2501176 | 0.83 | KDM1A (0.40) | KDM1AKDM1B | |
| SCHEMBL2450926 | 0.82 | MAOA (0.47) | MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2367820-B1 | NOVEL ANTIMICROBIAL AGENTS | PANACEA BIOTEC LTD (IN) | 2016-09-21 | — | — | EP | disclosed |
| US-8841306-B2 | Antimicrobials | PANACEA BIOTEC LTD. (IN) | 2014-09-23 | — | — | US | disclosed |
| US-20110245258-A1 | NOVEL ANTIMICROBIALS | PANACEA BIOTEC LTD. (IN) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245258-A1 | NOVEL ANTIMICROBIALS | ECI1, XDH, CYP3A4 | MAOA 269/4885KCNH2 3651/4885KDM1A 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.